77 related articles for article (PubMed ID: 7257970)
1. [Induction of experimental posterior subcapsular cataracts by vincristine sulfate and 1-beta-D-arabinofuranosylcytosine (ara C) (author's transl)].
Mikuni I; Fujiwara T; Obazawa H
Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1532-40. PubMed ID: 7257970
[No Abstract] [Full Text] [Related]
2. Experimental posterior subcapsular cataracts-with special reference to 1-beta-D-arabinofuranosyl-cytosine (Ara C)-induced cataracts.
Mikuni I; Fujiwara T; Obazawa H
Tokai J Exp Clin Med; 1981 Jan; 6(1):69-76. PubMed ID: 7256796
[TBL] [Abstract][Full Text] [Related]
3. [Experimental cortical subcapsular cataract induced by vincristine sulfate in vitro (author's transl)].
Mikuni I; Fujiwara T; Obazawa H
Nippon Ganka Gakkai Zasshi; 1979 Aug; 83(8):1241-51. PubMed ID: 525557
[No Abstract] [Full Text] [Related]
4. Experimental posterior subcapsular cortical cataracts caused by vincristine sulfate.
Mikuni I; Fujiwara T; Obazawa H
Tokai J Exp Clin Med; 1980 Jan; 5(1):29-39. PubMed ID: 7385261
[TBL] [Abstract][Full Text] [Related]
5. Histological comparison of senile posterior subcapsular cortical cataract and experimental posterior subcapsular cortical cataract induced by vincristine sulfate.
Mikuni I
Tokai J Exp Clin Med; 1980 Apr; 5(2):243-50. PubMed ID: 7414635
[TBL] [Abstract][Full Text] [Related]
6. Posterior subcapsular cortical cataract by inhibitor on DNA replication.
Mikuni I
Tokai J Exp Clin Med; 1980 Jul; 5(3):293-300. PubMed ID: 7222122
[TBL] [Abstract][Full Text] [Related]
7. [Experimental cataract in vitro induced by antimetabolites (author's transl)].
Mikuni I; Fujiwara T
Nippon Ganka Gakkai Zasshi; 1978 Apr; 82(4):282-7. PubMed ID: 665456
[No Abstract] [Full Text] [Related]
8. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
Sone S; Ishii K; Tsuruo T
Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
[TBL] [Abstract][Full Text] [Related]
9. [The simultaneous determination of Ara-U and Ara-C, urinary metabolites of N4-behenoyl-1-beta-D-arabinofuranosylcytosine by mass fragmentography (author's transl)].
Makino Y; Matsubara Y; Watanabe K; Hirobe M
Yakugaku Zasshi; 1982 Jan; 102(1):49-55. PubMed ID: 7086638
[No Abstract] [Full Text] [Related]
10. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
[TBL] [Abstract][Full Text] [Related]
11. [Lens induced myopia in steroid cataracts (author's transl)].
Koch HR; Siedek M
Klin Monbl Augenheilkd; 1977 Oct; 171(4):620-2. PubMed ID: 338967
[TBL] [Abstract][Full Text] [Related]
12. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
Danhauser LL; Rustum YM
Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
[TBL] [Abstract][Full Text] [Related]
13. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
Liliemark JO; Plunkett W; Dixon DO
Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067
[TBL] [Abstract][Full Text] [Related]
14. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
15. [Galactose cataract and metabolic role of glutathione in lenses. I. The therapeutic effect of glutathione on galactose cataract (author's transl)].
Imai Y
Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):177-85. PubMed ID: 1171607
[No Abstract] [Full Text] [Related]
16. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
17. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells.
Tsuruo T; Iida H; Hori K; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 Nov; 41(11 Pt 1):4484-8. PubMed ID: 7306971
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
[TBL] [Abstract][Full Text] [Related]
19. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
Lauzon GJ; Paterson AR; Belch AW
Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
